Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

Figure 2

Increased expression of CD86 on naïve and memory B cells from rheumatoid arthritis (RA) patients. (a) Dot plots representative of the expression of CD86 on B cells from an RA patient (left) and a healthy control (HC) (right). The number in the quadrant represents the percentage of CD19+ CD86+ cells. Graphics summarizing the percentages of CD86+ cells among naïve B cells (b), memory B cells (c), and plasmablasts (d) from 18 RA patients and 9 HCs. *P < 0.05, two-tailed Mann-Whitney U test. Horizontal lines represent mean values.

Back to article page